When was Magnendo founded?

Magnendo was founded in 2024 and raised its 1st funding round within a year of its incorporation.

Where is Magnendo located?

Magnendo is headquartered in Boston, United States.

Who is the current CEO of Magnendo?

Yoonho Kim of Magnendo. They have also founded 1 company.

How many employees does Magnendo have?

As of Aug 31, 2026, the latest employee count at Magnendo is 6.

Is Magnendo a funded company?

Magnendo is a funded company, having raised a total of $20.3M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 05, 2024.

When was the latest funding round of Magnendo?

Magnendo's latest funding was a $***** Grant (prize money) round on Aug 08, 2026, with participation from 1 investor.

Where does Magnendo rank among its competitors?

Magnendo ranks 3rd amongst 28 active competitors, of which 9 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Magnendo, which secured $32M in Aug, 2026.

Who are the top competitors of Magnendo?

Magnendo's top competitors include Route 92 Medical, Autonomix and Aneuvo. Among them, Magnendo secured the most recent funding round in August, 2026.

Magnendo - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a device for the treatment of neurovascular diseases. It offers magnetically steerable soft-robotic guidewires for minimally invasive procedures to transform the treatment of stroke and brain aneurysms. It targets in the brain's vasculature, reducing procedural time and complications to improve patient outcomes.

Website: www.magnendo.com/
Email ID: *****@magnendo.com

Key Metrics

Founded Year

2024

Location

Boston, United States

Stage

Series A

Total Funding

$20.3M in 3 rounds

Latest Funding Round

Grant (prize money), Aug 08, 2026, $*****

Investors

Penumbra & 1 more

Ranked

3^rd among 28 active competitors

Employee Count

6 as on Aug 31, 2026

Similar Companies

Route 92 Medical & 27 more

View Magnendo's full profile

Magnendo has raised a total funding of $20.3M over 3 rounds. Its first funding round was on Jun 05, 2024. Its latest funding round was a Grant (prize money) round on Aug 08, 2026 for $*****. 1 investor participated in its latest round. Magnendo has 2 institutional investors.

Here is the list of recent funding rounds of Magnendo:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 08, 2026	6058900	Grant (prize money)	6406736	2584473	8844826	9967314
Jul 17, 2026	9984778	Series A	4117740	1375572	1794367	2757394
Jun 05, 2024	7636382	Seed	8129349	6199007	4764465	7524980

Access funding benchmarks and valuations. Sign up today!

View details of Magnendo's funding rounds and investors

The founders of Magnendo is Yoonho Kim. Yoonho Kim is the CEO of Magnendo.

Here are the details of Magnendo's key team members:

Yoonho Kim: Founder & CEO of Magnendo.

View details of Magnendo's Founder profiles and Board Members

Magnendo's employee count trend

Magnendo has 6 employees as of Aug 26. Here is Magnendo's employee count trend over the years:

Uncover Magnendo's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Magnendo include Route 92 Medical, Autonomix and Aneuvo. Here is the list of Top 10 competitors of Magnendo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Route 92 Medical 2015, San Mateo (United States), Series F	Developer of next-generation products for neurointerventional procedures	$217M	Novo Holdings, InnovaHealth Partners & 6 others	63/100
2nd	Autonomix 2014, The Woodlands (United States), Public	Developer of minimally invasive neural monitoring and treatment devices	$8.2M	-	54/100
3rd	Magnendo 2024, Boston (United States), Series A	Developer of a device for the treatment of neurovascular diseases	$20.3M	Arpa H & 1 others	54/100
4th	Aneuvo 2016, Los Angeles (United States), Series C	Developer of a medical device for the treatment of spinal cord injuries	$22M	Catcher Technology	47/100
5th	Artiria 2019, Lausanne (Switzerland), Series A	Developer of micro-navigation system for stroke surgery	$9.19M	Verve Ventures, 4FOX Ventures & 9 others	42/100
6th	SonicBCI China, Seed	Developer of non-invasive transcranial focused ultrasound systems using artificial intelligence	$14.8M	Matrix Partners China, Delian Capital & 1 others	33/100
7th	Balt 1977, Montmorency (France), Funding Raised	Provider of neurovascular intervention devices and relevant solutions for physicians	-	Bridgepoint Group, Economy And Finance	33/100
8th	Capri-Medical 2018, Dublin (Ireland), Funding Raised	Developer of injectable devices for the treatment of neurological conditions	-	EIC Fund, Europa	32/100
9th	Neuro Front 2020, Pudong (China), Funding Raised	Developer of transformation medicines for neurological disorders	-	Pivotal bioVenture Partners China, Nan Fung Life Sciences ... Read more	29/100
10th	Shenzhen Yinghe Brain Science 2022, China, Seed	Developer of neuromodulation device to treat neurological diseases	$14.7M	Bangqin Capital, Lilly Asia Ventures & 3 others	28/100